Indication · Neurology & Neurosurgery
Dystonia
Last checked: Nov 20, 2026Source: FDA, ClinicalTrials.gov
Devices
13
Cleared or approved since 2000
PMA and De Novo
13
Higher-risk or first-of-kind devices
Breakthrough devices
0
Authorized through June 30, 2026
Recruiting device trials
28
115 device trials in all
Devices
13 devices via PMA. PMA and De Novo devices first, then devices with the most FDA decisions. Each opens a full summary.
- Vercise Genus DBS System, Vercise Gevia DBS System, Vercise PC DBS System
Boston Scientific Corp · PMA · Stimulator, Electrical, Implanted, For Parkinsonian Symptoms · newest 2024 · 4 decisions
12 more devices with a free account
Device trials
Device studies on ClinicalTrials.gov for this condition, any status, newest update first.
National Institute of Neurological Disorders and Stroke (NINDS)NIH
NCT01581580 · 200 participants (planned) · Start Aug 17, 2011 · Primary completion Dec 1, 2029
Device: Medtronic Activa Tremor Control System · For: Parkinson's Disease; Essential Tremor; Dystonia
Sites: Bethesda, Maryland
114 more trials with a free account
Device types
FDA product codes mapped to this indication. The mapping was made with AI help and may include a few loose fits.
Research
- Device studies on dystonia across PubMed, Europe PMC and OpenAlex
- PubMed ↗
- Google Scholar ↗
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.